The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Revenue of Musclepharm from 2017 to 2021 (in million U.S. dollars)
Musclepharm revenue 2017-2021
The revenue of Musclepharm with headquarters in the United States amounted to million U.S. dollars in 2021. The reported fiscal year ends on December 31.
Compared to the earliest depicted value from 2017 this is a total decrease by approximately million U.S. dollars. The trend from 2017 to 2021 shows, furthermore, that this decrease happened continuously.
Compared to the earliest depicted value from 2017 this is a total decrease by approximately million U.S. dollars. The trend from 2017 to 2021 shows, furthermore, that this decrease happened continuously.
Log in or register to access precise data.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Natural Alternatives revenue 2021-2025
- Premium Statistic Cyanotech Corp revenue 2020-2024
- Premium Statistic Grace Therapeutics, Inc. revenue 2020-2021
- Premium Statistic Neuropathix, Inc. revenue 2017-2021
- Premium Statistic Nanomix Corp revenue 2018-2022
- Premium Statistic Axim Biotechnologies revenue 2019-2023
- Premium Statistic Aytu Bioscience revenue 2021-2025
- Premium Statistic Chemocentryx, Inc. revenue 2017-2021
- Premium Statistic Niagen Bioscience, Inc. revenue 2021-2025
- Premium Statistic Neutra Corp. revenue 2019-2022
About the region
10
- Premium Statistic Crown Crafts revenue 2020-2024
- Premium Statistic Cardiovascular Systems Inc revenue 2018-2022
- Premium Statistic Nbt Bancorp revenue 2021-2025
- Premium Statistic Motos America, Inc. revenue 2018-2022
- Premium Statistic Cvd Equipment revenue 2021-2025
- Premium Statistic Audioeye revenue 2021-2025
- Premium Statistic Cv Sciences, Inc. revenue 2021-2025
- Premium Statistic Cs Disco revenue 2021-2025
- Premium Statistic Cto Realty Growth revenue 2021-2025
- Premium Statistic National Health Investors Inc revenue 2021-2025
Selected statistics
10
- Premium Statistic Neogen revenue 2020-2024
- Premium Statistic Phibro Animal Health revenue 2021-2025
- Premium Statistic Pacira Biosciences revenue 2021-2025
- Premium Statistic Canopy Growth revenue 2021-2025
- Premium Statistic Medios revenue 2021-2025
- Premium Statistic Alcon revenue 2021-2025
- Premium Statistic China Resources Pharmaceutical revenue 2022-2025
- Premium Statistic H.U. Group Holdings, Inc. revenue 2020-2024
- Premium Statistic Sichuan Kelun Pharmaceutical Co., Ltd. revenue 2021-2025
- Premium Statistic FOSUN PHARM revenue 2021-2025
Other regions
10
- Premium Statistic Travis Perkins revenue 2019-2020
- Premium Statistic Sandhar Technologies Limited revenue 2021-2025
- Premium Statistic Sakthi Sugars Limited revenue 2021-2025
- Premium Statistic Safari Industries (India) Limited revenue 2021-2025
- Premium Statistic Sportking India Limited revenue 2021-2025
- Premium Statistic Sangam (India) Limited revenue 2021-2025
- Premium Statistic The Bombay Dyeing and Manufacturing Company Limited revenue 2021-2025
- Premium Statistic Simbhaoli Sugars Limited revenue 2020-2024
- Premium Statistic The Hi-Tech Gears Limited revenue 2020-2024
- Premium Statistic Sumeet Industries Limited revenue 2020-2024
Related statistics
10
- Premium Statistic Ascent Industries Co. revenue 2021-2025
- Premium Statistic Cardio Diagnostics Holdings, Inc. revenue 2021-2025
- Premium Statistic Artivion, Inc. revenue 2021-2025
- Premium Statistic Culp revenue 2020-2024
- Premium Statistic Nephros revenue 2021-2025
- Premium Statistic Acutus Medical revenue 2020 to 2024
- Premium Statistic National Presto Industries revenue 2021-2025
- Premium Statistic Nektar Therapeutics revenue 2021-2025
- Premium Statistic Nate's Foods revenue 2017-2022
- Premium Statistic Arvinas revenue 2021-2025
Further Content: You might find this interesting as well
U.S. Securities and Exchange Commission. (October 24, 2024). Revenue of Musclepharm from 2017 to 2021 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 23, 2026, from /forecasts/1506947/musclepharm-revenue/
U.S. Securities and Exchange Commission. "Revenue of Musclepharm from 2017 to 2021 (in million U.S. dollars)." Chart. October 24, 2024. ÌÇÐÄÆÆ½â°æ. Accessed July 23, 2026. /forecasts/1506947/musclepharm-revenue/
U.S. Securities and Exchange Commission. (2024). Revenue of Musclepharm from 2017 to 2021 (in million U.S. dollars). ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 23, 2026. /forecasts/1506947/musclepharm-revenue/
U.S. Securities and Exchange Commission. "Revenue of Musclepharm from 2017 to 2021 (in Million U.S. Dollars)." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 24 Oct 2024, /forecasts/1506947/musclepharm-revenue/
U.S. Securities and Exchange Commission, Revenue of Musclepharm from 2017 to 2021 (in million U.S. dollars) ÌÇÐÄÆÆ½â°æ, /forecasts/1506947/musclepharm-revenue/ (last visited July 23, 2026)
Revenue of Musclepharm from 2017 to 2021 (in million U.S. dollars) [Graph], U.S. Securities and Exchange Commission, October 24, 2024. [Online]. Available: /forecasts/1506947/musclepharm-revenue/
Advertisement









